Psyence Biomedical Ltd. (PBM) NASDAQ
6.25
-0.34(-5.16%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.25
-0.34(-5.16%)
Currency In USD
| Market Cap | 14.31M |
| Enterprise Value | 8.18M |
| P/E Ratio | 3.51 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.53 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.87 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | 0.14 |
| Return On Equity | -0.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -4,268 |
| EBITDA | 1.03M |
| Net Income | 1.01M |
| Diluted EPS | 1.78 |
| Total Cash | 7.2M |
| Total Cash/Share | 10.8 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 11.04 |
| Book Value Per Share | 11.83 |
| 52-Week Change | -65.73 |
| 52-Week High | 468.36 |
| 52-Week Low | 1.92 |
| Moving Average 50 Days | 3.75 |
| Moving Average 200 Days | 76.52 |
| Average Volume | 2.66M |
| Shares Outstanding | 19,019 |
| % Held by Institutions | 103.98 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | February 02, 2026 |